CLINICAL_TRIALS
research
· 2015-08-20
Clinical Trial Update: Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone Marrow Transplantation (BMT) in Patients With Multiple Sclerosis (MS) [NA]
Summary
A clinical trial update describes a conditioning protocol for autologous bone marrow transplantation in multiple sclerosis, evaluating safety and efficacy, with…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Multiple Sclerosis | NA | Status: UNKNOWN